A novel wistar rat model of obesity-related nonalcoholic fatty liver disease induced by sucrose-rich diet

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Lima, Maria Luíza R P ^a   Leite, Laura H R ^b   Gioda, Carolina R ^c   Leme, Fabíola O P ^a   Couto, Claudia A ^a   Coimbra, Cândido C ^a   Leite, Virginia H R ^a   Ferrari, Teresa Cristina A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CATALASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; MALONALDEHYDE; SUCROSE; SUPEROXIDE DISMUTASE; VERY LOW DENSITY LIPOPROTEIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LEPTIN; LIPID; SUGAR INTAKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BODY MASS; CHEST CIRCUMFERENCE; CONTROLLED STUDY; DIET; DIET INDUCED OBESITY; DISEASE ASSOCIATION; FATTY LIVER; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLEPTINEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIVER HISTOLOGY; MALE; METABOLISM; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRAINING; ANIMAL; BLOOD; DISEASE MODEL; GLUCOSE BLOOD LEVEL; KINESIOTHERAPY; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PROCEDURES; RUNNING; SUGAR INTAKE; TIME FACTOR; WISTAR RAT;

ANIMALS; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CATALASE; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; EXERCISE THERAPY; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPIDS; LIVER; MALE; MALONDIALDEHYDE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXIDATIVE STRESS; RATS, WISTAR; RUNNING; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 84953898184     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/9127076     Document Type: Article

References (72)

1. K. Hassan, V. Bhalla, M. E. El Regal, and H. Hesham A-Kader, "Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic," World Journal of Gastroenterology, vol. 20, no. 34, pp. 12082-12101, 2014.
2. S. S. Elliott, N. L. Keim, J. S. Stern, K. Teff, and P. J. Havel, "Fructose, weight gain, and the insulin resistance syndrome," The American Journal of Clinical Nutrition, vol. 76, no. 5, pp. 911-922, 2002.
3. V. S. Malik and F. B. Hu, "Sweeteners and risk of obesity and type 2Diabetes: the role of sugar-sweetened beverages," Current Diabetes Reports, vol. 12, no. 2, pp. 195-203, 2012.
4. E. Ravussin, "Physiology: a NEAT way to control weight?" Science, vol. 307, no. 5709, pp. 530-531, 2005.
5. C. D. Byrne and G. Targher, "NAFLD: a multisystem disease," Journal of Hepatology, vol. 62, no. 1, pp. S47-S64, 2015.
6. J. P. Ong and Z. M. Younossi, "Epidemiology and natural history of NAFLD and NASH," Clinics in Liver Disease, vol. 11, no. 1, pp. 1-16, 2007.
7. B. Q. Starley, C. J. Calcagno, and S. A. Harrison, "Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection," Hepatology, vol. 51, no. 5, pp. 1820-1832, 2010.
8. S. M. El-Kader and E. M. El-Den Ashmawy, "Non-alcoholic fatty liver disease: the diagnosis and management," World Journal of Hepatology, vol. 7, no. 6, pp. 846-858, 2015.
9. G. Marchesini, M. Brizi, A. M. Morselli-Labate et al., "Association of nonalcoholic fatty liver disease with insulin resistance," The American Journal of Medicine, vol. 107, no. 5, pp. 450-455, 1999.
10. A. J. Sanyal, C. Campbell-Sargent, F. Mirshahi et al., "Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities," Gastroenterology, vol. 120, no. 5, pp. 1183-1192, 2001.
11. E. Albano, E. Mottaran, M. Vidali et al., "Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis," Gut, vol. 54, no. 7, pp. 987-993, 2005.
12. Q. M. Anstee and R. D. Goldin, "Mousemodels in non-alcoholic fatty liver disease and steatohepatitis research," International Journal of Experimental Pathology, vol. 87, no. 1, pp. 1-16, 2006.
13. F. Marra, A. Gastaldelli, G. Svegliati Baroni, G. Tell, and C. Tiribelli, "Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis," Trends in Molecular Medicine, vol. 14, no. 2, pp. 72-81, 2008.
14. Y. Takahashi, Y. Soejima, and T. Fukusato, "Animal models of nonalcoholic fatty liver disease/ nonalcoholic steatohepatitis," World Journal of Gastroenterology, vol. 18, no. 19, pp. 2300-2308, 2012.
15. J. A. Harrold, P. S. Widdowson, J. C. Clapham, and G. Williams, "Individual severity of dietary obesity in unselected Wistar rats: relationship with hyperphagia," The American Journal of Physiology-Endocrinology and Metabolism, vol. 279, no. 2, pp. E340-E347, 2000.
16. E. L. B. Novelli, Y. S. Diniz, C. M. Galhardi et al., "Anthropometrical parameters and markers of obesity in rats," Laboratory Animals, vol. 41, no. 1, pp. 111-119, 2007.
17. F. Priviero, G. De Nucci, E. Antunes, and A. Zanesco, "Negative chronotropic response to adenosine receptor stimulation in rat right atria after run training," Clinical and Experimental Pharmacology and Physiology, vol. 31, no. 10, pp. 741-743, 2004.
18. S. Dieterich, U. Bieligk, K. Beulich, G. Hasenfuss, and J. Prestle, "Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart," Circulation, vol. 101, no. 1, pp. 33-39, 2000.
19. D. P. Nelson and L. A. Kiesow, "Enthalpy of decomposition of hydrogen peroxide by catalase at 25° C (with molar extinction coefficients of H2O2 solutions in the UV)," Analytical Biochemistry, vol. 49, no. 2, pp. 474-478, 1972.
20. E. M. Brunt, C. G. Janney, A. M. Di Bisceglie, B. A. Neuschwander-Tetri, and B. R. Bacon, "Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions," The American Journal of Gastroenterology, vol. 94, no. 9, pp. 2467-2474, 1999.
21. C. S. Lieber, M. A. Leo, K. M. Mak et al., "Model ofnonalcoholic steatohepatitis,"The American Journal of Clinical Nutrition, vol. 79, no. 3, pp. 502-509, 2004.
22. B. Wahlang, K. C. Falkner, B. Gregory et al., "Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice," The Journal of Nutritional Biochemistry, vol. 24, no. 9, pp. 1587-1595, 2013.
23. A. Nakamura and Y. Terauchi, "Lessons from mouse models of high-fat diet-induced NAFLD," International Journal of Molecular Sciences, vol. 14, no. 11, pp. 21240-21257, 2013.
24. S. J. Lee, J. H. Kang, S. Y. Choi, K. T. Suk, D. J. Kim, and O.-S. Kwon, "PKCδ as a regulator for TGFβ1-induced α-SMA production in a murine nonalcoholic steatohepatitis model," PLoS ONE, vol. 8, no. 2, Article ID e55979, 2013.
25. H. Okubo, H. Sakoda, A. Kushiyama et al., "Lactobacillus casei strain shirota protects against nonalcoholic steatohepatitis development in a rodent model," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 305, no. 12, pp. G911-G918, 2013.
26. M. K. Pickens, H. Ogata, R. K. Soon, J. P. Grenert, and J. J. Maher, "Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet," Liver International, vol. 30, no. 8, pp. 1229-1239, 2010.
27. T. Ishimoto, M. A. Lanaspa, C. J. Rivard et al., "High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase," Hepatology, vol. 58, no. 5, pp. 1632-1643, 2013.
28. R. Kohli, M. Kirby, S. A. Xanthakos et al., "High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis," Hepatology, vol. 52, no. 3, pp. 934-944, 2010.
29. C. Dorn, J. C. Engelmann, M. Saugspier et al., "Increasedexpression of c-Jun in nonalcoholic fatty liver disease," Laboratory Investigation, vol. 94, no. 4, pp. 394-408, 2014.
30. J. P. Son, M.-K. Son, S.-W. Jun et al., "Effects of a new sustainedrelease microsphere formulation of exenatide, DA-3091, on obese and non-alcoholic fatty liver disease mice," Pharmazie, vol. 68, no. 1, pp. 58-62, 2013.
31. B.-H. Liu, Y.-Y. Lin, Y.-C. Wang et al., "Porcine adiponectin receptor 1 transgene resists high-fat/sucrose diet-induced weight gain, hepatosteatosis and insulin resistance in mice," Experimental Animals, vol. 62, no. 4, pp. 347-360, 2013.
32. S. K. Panchal, H. Poudyal, J. Waanders, and L. Brown, "Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in highcarbohydrate, high-fat diet-fed male rats," The Journal of Nutrition, vol. 142, no. 4, pp. 690-697, 2012.
33. Z. Qi, J. Xue, Y. Zhang, H. Wang, and M. Xie, "Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats," Planta Medica, vol. 77, no. 3, pp. 231-235, 2011.
34. M. Aoun, F. Michel, G. Fouret et al., "A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats: possible implication of the sirtuin pathway," British Journal of Nutrition, vol. 104, no. 12, pp. 1760-1770, 2010.
35. J.-H. Fu, H.-S. Sun, Y. Wang, W.-Q. Zheng, Z.-Y. Shi, and Q.-J. Wang, "Theeffects of a fat-and sugar-enriched diet and chronic stress on nonalcoholic fatty liver disease in male wistar rats," Digestive Diseases and Sciences, vol. 55, no. 8, pp. 2227-2236, 2010.
36. F. Armutcu, O. Coskun, A. Gürel et al., "Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats," Clinical Biochemistry, vol. 38, no. 6, pp. 540-547, 2005.
37. A. Spruss, G. Kanuri, S. Wagnerberger, S. Haub, S. C. Bischoff, and I. Bergheim, "Toll-like receptor-4 is involved in the development of fructose-induced hepatic steatosis in mice," Hepatology, vol. 50, no. 4, pp. 1094-1104, 2009.
38. T. Kawasaki, K. Igarashi, T. Koeda et al., "Rats fed fructoseenriched diets have characteristics of nonalcoholic hepatic steatosis," Journal of Nutrition, vol. 139, no. 11, pp. 2067-2071, 2009.
39. L. G. Sanchez-Lozada, W. Mu, C. Roncal et al., "Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver," European Journal of Nutrition, vol. 49, no. 1, pp. 1-9, 2010.
40. K. Nomura and T. Yamanouchi, "The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease," The Journal of Nutritional Biochemistry, vol. 23, no. 3, pp. 203-208, 2012.
41. K. Nojima, K. Sugimoto, H. Ueda, N. Babaya, H. Ikegami, and H. Rakugi, "Analysis of hepatic gene expression profile in a spontaneous mouse model of type 2 diabetes under a high sucrose diet," Endocrine Journal, vol. 60, no. 3, pp. 261-274, 2013.
42. Y.-S. Song, C.-H. Fang, B.-I. So, J.-Y. Park, D. W. Jun, and K.-S. Kim, "Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat," Annals of Hepatology, vol. 12, no. 1, pp. 115-122, 2013.
43. C. A. Roncal-Jimenez, M. A. Lanaspa, C. J. Rivard et al., "Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake," Metabolism: Clinical and Experimental, vol. 60, no. 9, pp. 1259-1270, 2011.
44. V. Volynets, A. Spruss, G. Kanuri, S. Wagnerberger, S. C. Bischoff, and I. Bergheim, "Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice," The Journal of Lipid Research, vol. 51, no. 12, pp. 3414-3424, 2010.
45. E. Ip, G. C. Farrell, G. Robertson, P. Hall, R. Kirsch, and I. Leclercq, "Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice," Hepatology, vol. 38, no. 1, pp. 123-132, 2003.
46. M. Carmiel-Haggai, A. I. Cederbaum, and N. Nieto, "A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats," The FASEB Journal, vol. 19, no. 1, pp. 136-138, 2005.
47. K. Wouters, P. J. van Gorp, V. Bieghs et al., "Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis," Hepatology, vol. 48, no. 2, pp. 474-486, 2008.
48. B. A. Neuschwander-Tetri, "Carbohydrate intake and nonalcoholic fatty liver disease," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 16, no. 4, pp. 446-452, 2013.
49. P. Paschos and K. Paletas, "Non alcoholic fatty liver disease and metabolic syndrome," Hippokratia, vol. 13, no. 1, pp. 9-19, 2009.
50. J. D. Sparks, C. E. Sparks, and K. Adeli, "Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 9, pp. 2104-2112, 2012.
51. J.-M. Schwarz, P. Linfoot, D. Dare, and K. Aghajanian, "Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and lowfat, high-carbohydrate isoenergetic diets,"TheAmerican Journal of Clinical Nutrition, vol. 77, no. 1, pp. 43-50, 2003.
52. A. Aarsland, D. Chinkes, and R. R. Wolfe, "Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man,"The Journal of Clinical Investigation, vol. 98, no. 9, pp. 2008-2017, 1996.
53. L. C. Hudgins, M. K. Hellerstein, C. E. Seidman, R. A. Neese, J. D. Tremaroli, and J. Hirsch, "Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects," The Journal of Lipid Research, vol. 41, no. 4, pp. 595-604, 2000.
54. J. M. Friedman and J. L. Halaas, "Leptin and the regulation of body weight in mammals," Nature, vol. 395, no. 6704, pp. 763-770, 1998.
55. L. Vila, N. Roglans, M. Alegret, R. M. Sanchez, M. Vazquez-Carrera, and J. C. Laguna, "Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of Fructose on rat liver lipid metabolism," Hepatology, vol. 48, no. 5, pp. 1506-1516, 2008.
56. S. Chitturi, G. Farrell, L. Frost et al., "Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: amanifestation of lipotoxicity?" Hepatology, vol. 36, no. 2, pp. 403-409, 2002.
57. C. S. Mantzoros, "The role of leptin and hypothalamic neuropeptides in energy homeostasis: update on leptin in obesity," Growth Hormone and IGF Research, vol. 11, supplement A, pp. S85-S89, 2001.
58. W. Huang, N. Dedousis, A. Bandi, G. D. Lopaschuk, and R. M. ODoherty, "Liver triglyceride secretion and lipid oxidative metabolismare rapidly altered by leptin in vivo," Endocrinology, vol. 147, no. 3, pp. 1480-1487, 2006.
59. L. J. Brady, P. S. Brady, D. R. Romsos, and C. L. Hoppel, "Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ob) mice," Biochemical Journal, vol. 231, no. 2, pp. 439-444, 1985.
60. Q. Cao, K. M. Mak, C. Ren, and C. S. Lieber, "Leptin stimulates tissue inhibitor ofmetalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK/STAT and JAK-mediated H2O2-dependentMAPKpathways," Journal of Biological Chemistry, vol. 279, no. 6, pp. 4292-4304, 2004.
61. H. Sies and W. Stahl, "Vitamins E and C, beta-carotene, and other carotenoids as antioxidants," The American Journal of Clinical Nutrition, vol. 62, no. 6, supplement, pp. 1315S-1321S, 1995.
62. O. F. W. James and C. P. Day, "Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance," Journal of Hepatology, vol. 29, no. 3, pp. 495-501, 1998.
63. S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa, "In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases," Journal of Hepatology, vol. 37, no. 1, pp. 56-62, 2002.
64. J. Busserolles, E. Gueux, E. Rock, A. Mazur, and Y. Rayssiguier, "Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose," The Journal of Nutrition, vol. 132, no. 11, pp. 3379-3382, 2002.
65. I. A. Leclercq, "Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis?" Clinical Science, vol. 106, no. 3, pp. 235-237, 2004.
66. J. L. Martindale and N. J. Holbrook, "Cellular response to oxidative stress: signaling for suicide and survival," Journal of Cellular Physiology, vol. 192, no. 1, pp. 1-15, 2002.
67. D. Pessayre, A. Mansouri, and B. Fromenty, "Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis," The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 282, no. 2, pp. G193-G199, 2002.
68. G. C. Farrell, D. van Rooyen, L. Gan, and S. Chitturi, "NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications," Gut and Liver, vol. 6, no. 2, pp. 149-171, 2012.
69. C. Y. Christ, D. Hunt, J. Hancock, R. Garcia-Macedo, L. J. Mandarino, and J. L. Ivy, "Exercise training improves muscle insulin resistance but not insulin receptor signaling in obese Zucker rats," Journal of Applied Physiology, vol. 92, no. 2, pp. 736-744, 2002.
70. J. L. Durstine, K. A. Kenno, and R. E. Shepherd, "Serum lipoproteins of the Zucker rat in response to an endurance running program,"Medicine and Science in Sports and Exercise, vol. 17, no. 5, pp. 567-573, 1985.
71. C. H. D. J. Pinheiro, W. M. D. S. Filho, J. D. O. Neto et al., "Exercise prevents cardiometabolic alterations induced by chronic use of glucocorticoids," Arquivos Brasileiros de Cardiologia, vol. 93, no. 4, pp. 372-408, 2009.
72. W. Aoi, Y. Naito, L. P. Hang et al., "Regular exercise prevents high-sucrose diet-induced fatty liver via improvement of hepatic lipid metabolism," Biochemical and Biophysical Research Communications, vol. 413, no. 2, pp. 330-335, 2011.